Kim, Kwanghee <br/><br/>
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.  [electronic resource] 

 -  Nature communications  04 2020 
 - 1975 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-020-15885-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Biopsy<br/>Camptothecin--analogs & derivatives<br/>Carcinoma, Transitional Cell--genetics<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Variation<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Immunoconjugates--pharmacology<br/>Interleukin Receptor Common gamma Subunit--genetics<br/>Male<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Middle Aged<br/>Mutation<br/>Neoplasm Metastasis<br/>Neoplasm Transplantation<br/>Phenotype<br/>Precision Medicine<br/>Prospective Studies<br/>Quinolines--pharmacology<br/>Retrospective Studies<br/>Sequence Analysis, RNA<br/>Trastuzumab<br/>Urinary Bladder Neoplasms--genetics<br/>Urothelium--pathology